NIH Funding · FY2024
Total Funding
$674.3K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#23,203
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $674.3K across 1 grant · National rank #23203.
Top grants by award amount
Brandon Smaglo's NIH grant portfolio, ranked by award amount.
- 1R44CA295168-01R44A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Specific T Cells (MT-601) Administered to Patients with Metastatic Pancreatic Cancer following frontline FOLFIRINOX$674.3Kaward amount
Affiliation
Institutions that have administered grants for Brandon Smaglo.
Affiliated with Marker Therapeutics, Inc. (TX).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardMarker Therapeutics, Inc.
- 2024$500K Cumulative Funding
Related investigators
Other NIH-funded PIs frequently associated with Brandon Smaglo.
Explore further
Find collaborators for Brandon Smaglo
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Marker Therapeutics, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →